Your browser doesn't support javascript.
loading
[Long-term safety and activity of humanized CD19 chimeric antigen receptor T cells for children and young adults with relapsed/refractory acute lymphoblastic leukemia].
Wang, S Y; Zhao, L N; Cheng, H; Shi, M; Chen, W; Qi, K M; Sun, C; Wang, X; Cao, J; Xu, K L.
Afiliación
  • Wang SY; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China.
  • Zhao LN; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China.
  • Cheng H; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China.
  • Shi M; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China.
  • Chen W; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China.
  • Qi KM; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China.
  • Sun C; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China.
  • Wang X; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China.
  • Cao J; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China.
  • Xu KL; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China.
Zhonghua Xue Ye Xue Za Zhi ; 43(7): 557-561, 2022 Jul 14.
Article en Zh | MEDLINE | ID: mdl-36709132

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Receptores Quiméricos de Antígenos Tipo de estudio: Prognostic_studies Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Receptores Quiméricos de Antígenos Tipo de estudio: Prognostic_studies Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Año: 2022 Tipo del documento: Article